MD Anderson and WHO Establish a New International Collaboration to Reduce the Global Burden of Women’s Cancers
The University of Texas MD Anderson Cancer Center and the World Health Organization (WHO) recently announced a formal agreement to establish a new international collaboration concentrated on reducing the global burden of women’s cancers. The agreement builds on years of collaboration between the two institutions to further promote their shared efforts in advancing global cancer initiatives in women’s cancers, including breast and cervical cancers.
Peter WT Pisters, MD
“Collaborating with WHO aligns with MD Anderson’s mission to provide exceptional cancer care to people in Texas, the country, and around the globe through programs that integrate patient care, research, prevention, and education,” said Peter WT Pisters, MD, President of MD Anderson. “It also aligns with our institution’s strategy and our commitment to building strong international relationships to serve the global community and improve quality of life at the population level.”
WHO aims to support members of the United Nations in strengthening their cancer control programs through global cancer initiatives like women’s and childhood cancers. As one of WHO’s adult cancer collaborators, MD Anderson has worked previously with WHO to treat patients with cancer at various WHO disease sites and has assisted in strengthening its cancer control programs.
Through this collaboration, MD Anderson experts will support WHO in cancer-related efforts and will lend their knowledge and expertise to provide training materials for the implementation of WHO cancer initiatives.